{"id":264091,"date":"2026-09-23T12:10:25","date_gmt":"2026-09-23T06:40:25","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=264091"},"modified":"2026-09-23T12:10:25","modified_gmt":"2026-09-23T06:40:25","slug":"specialty-dosage-stock-rises-116-percent-in-6-months","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/specialty-dosage-stock-rises-116-percent-in-6-months\/","title":{"rendered":"This Specialty Dosage Stock Rises 116% in 6 Months: What Is Driving the Re-Rating?"},"content":{"rendered":"

CMP Rs 1,654.90 (23 Sep 2026). Six-month return approximately 116%. 52W range Rs 570.75 to Rs 1,899. Market cap Rs 27,675 Cr. Q1 FY27 PAT Rs 84.78 Cr, up 96%.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Rubicon Research, a US-focused formulation maker, is the specialty dosage stock behind a six-month gain of approximately 116%, from Rs 767.40 on 23 March 2026 to Rs 1,654.90 on 23 September 2026. The move came from four consecutive earnings beats since its October 2025 listing, a clean USFDA outcome at Pithampur and a US plant purchase. A promoter block sale in August 2026 brought large funds onto the register at Rs 1,660. At approximately 96 times trailing earnings, the valuation leaves little room for a miss.<\/p>\n<\/div>\n

A specialty dosage stock on the NSE has risen approximately 116% in six months, from a close of Rs 767.40 on 23 March 2026 to Rs 1,654.90 on 23 September 2026. The company listed only in October 2025, and this specialty dosage stock doubled while the broader index fell.<\/p>\n

The company is Rubicon Research<\/a> Ltd<\/strong> (NSE: RUBICON), a Thane-headquartered formulation maker selling almost entirely into the United States. The Rubicon Research share price has run on four straight earnings beats since listing, a clean USFDA outcome at its newest plant, a US plant purchase and a promoter block sale that put marquee funds on the register.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n